Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Clinical Oncology: Case Reports
Jian-Xin Lv Author
Subjects of specialization
Affiliation
Genitourinary Cancer,Thoracic Cancer,Tumor,Ovarian Cancer,Targeted Therapy Immuno-Oncology
Zhejiang Provincial Key Laboratory of Medical Genetics,Wenzhou Medical College,Wenzhou ,China
Biography
Dr. Jian-Xin Lv, Zhejiang Provincial Key Laboratory of Medical Genetics,Wenzhou Medical College,Wenzhou ,China. Dr. Xin specializes in Genitourinary Cancer, Thoracic Cancer, Tumor, Targeted Therapy Immuno-Oncology
Publications
Review Article Open Access
The Progressive Journey from Ductal Carcinoma in situ into Invasive Breast Cancer: An Extensive Systematic Literature Review on Biomarkers
Author(s): Ercilia Da Gloria LI, Jian-Xin Lv, Guy-Armel Bounda, Xin-Hua Cao, Hao-Lin Hu and Ya-Nan Zhang* (China)
Breast Cancer (BC) is the most common cancer in women, and second most cancer worldwide. It is a progressive and fatal disease that affects women of all ages, and is divided into several subtypes with distinct histological, genomic and transcriptomic profiles, outcomes, and responses to therapy. Ductal carcinoma in situ (DCIS) is a pre-invasive stage in the development of invasive breast carcinoma. DCIS presents a clinical problem, with high risk of potential progressive disease. A subset of patients with ductal carcinoma in situ (DCIS) will develop Invasive Breast Cancer (IBC). Thus, biomarkers are pivotal important to help identify DCIS/ IBC genes that might probably lead to potential rational treatment therapies. While biomarkers are defined as indicators of normal biological process... view more»
Social Media